Efficient Elimination of Nonstoichiometric Enzyme Inhibitors from HTS Hit Lists

被引:27
作者
Habig, Michael
Blechschmidt, Anke [2 ]
Dressler, Sigmar
Hess, Barbara
Patel, Viral [3 ]
Billich, Andreas
Ostermeier, Christian [2 ]
Beer, David [3 ]
Klumpp, Martin [1 ]
机构
[1] Novartis Pharma AG, Novartis Inst Biomed Res Basel, Lead Finding Platform, Ctr Prot Chem, CH-4002 Basel, Switzerland
[2] Ctr Prote Chem, Novartis Inst Biomed Res, Prot Struct Unit, Basel, Switzerland
[3] Trop Dis Pte Ltd, Novartis Inst, Singapore, Singapore
基金
英国惠康基金;
关键词
high-throughput screening; stoichiometric inhibitors; stoichiometric binding; enzyme; HUMAN SPHINGOSINE KINASE; PROMISCUOUS INHIBITORS; COMPOUND LIBRARIES; PROTEIN-KINASE; ASSAY; DISCOVERY; TRANSCREENER(TM); MECHANISM; DETERGENT; LIGANDS;
D O I
10.1177/1087057109336586
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
High-throughput screening often identifies not only specific, stoichiometrically binding inhibitors but also undesired compounds that unspecifically interfere with the targeted activity by nonstoichiometrically binding, unfolding, and/or inactivating proteins. In this study, the effect of such unwanted inhibitors on several different enzyme targets was assessed based on screening results for over a million compounds. In particular, the shift in potency on variation of enzyme concentration was used as a means to identify nonstoichiometric inhibitors among the screening hits. These potency shifts depended on both compound structure and target enzyme. The approach was confirmed by statistical analysis of thousands of dose-response curves, which showed that the potency of competitive and therefore clearly stoichiometric inhibitors was not affected by increasing enzyme concentration. Light-scattering measurements of thermal protein unfolding further verified that compounds that stabilize protein structure by stoichiometric binding show the same potency irrespective of enzyme concentration. In summary, measuring inhibitor IC50 values at different enzyme concentrations is a simple, cost-effective, and reliable method to identify and eliminate compounds that inhibit a specific target enzyme via nonstoichiometric mechanisms. (Journal of Biomolecular Screening 2009:679-689)
引用
收藏
页码:679 / 689
页数:11
相关论文
共 36 条
[1]  
[Anonymous], 2005, LANG ENV STAT COMP
[2]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[3]   Fluorescence-based assay of sphingosine kinases [J].
Billich, A ;
Ettmayer, P .
ANALYTICAL BIOCHEMISTRY, 2004, 326 (01) :114-119
[4]   Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases [J].
Billich, A ;
Bornancin, F ;
Dévay, P ;
Mechtcheriakova, D ;
Urtz, N ;
Baumruker, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (48) :47408-47415
[5]  
Bonferroni C. E., 1935, Studi in Onore del Professore Salvatore Ortu Carboni, P13
[6]   Colloidal aggregate detection by rapid fluorescence measurement of liquid surface curvature changes in multiwell plates [J].
Cai, Lifeng ;
Gochin, Miriam .
JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (07) :966-971
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   Invariance and variability in bacterial PanK:: a study based on the crystal structure of Mycobacterium tuberculosis PanK [J].
Das, Satyabrata ;
Kumar, Parimal ;
Bhor, Vikrant ;
Surolia, A. ;
Vijayan, M. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2006, 62 :628-638
[9]   A detergent-based assay for the detection of promiscuous inhibitors [J].
Feng, Brian Y. ;
Shoichet, Brian K. .
NATURE PROTOCOLS, 2006, 1 (02) :550-553
[10]   A high-throughput screen for aggregation-based inhibition in a large compound library [J].
Feng, Brian Y. ;
Simeonov, Anton ;
Jadhav, Ajit ;
Babaoglu, Kerim ;
Inglese, James ;
Shoichet, Brian K. ;
Austin, Christopher P. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (10) :2385-2390